| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA751111 | F | Antagonist activity against recombinant rat receptor P2X purinoceptor 2 (P2X2) at 10 uM, expressed in Xenopus oocytes | 7 | ALA1135773 | cell-based format | Scientific Literature | ||
| 2. | ALA751807 | B | Affinity at P2X purinoceptor 3 (P2X3) and the value is expressed as IC50 | 1 | ALA1135726 | single protein format | Scientific Literature | ||
| 3. | ALA750979 | F | The compound was evaluated for antagonist activity against recombinant rat P2X purinoceptor 3 (P2X3) at 30 uM, expressed in Xenopus oocytes | Rattus norvegicus | 1 | ALA1135773 | cell-based format | Scientific Literature | |
| 4. | ALA750983 | B | KB value was evaluated at the human P2X purinoceptor 4 (P2X4); IA menas inactive | 1 | ALA1135726 | single protein format | Scientific Literature | ||
| 5. | ALA750986 | F | Antagonist activity against recombinant rat P2X purinoceptor 4 (P2X4) at 3 uM, expressed in Xenopus oocytes | 5 | ALA1135773 | cell-based format | Scientific Literature | ||
| 6. | ALA754457 | F | The compound was evaluated for antagonist activity against recombinant human P2X purinoceptor 7 (P2X7) | 1 | ALA1135773 | assay format | Scientific Literature | ||
| 7. | ALA751762 | F | Percentage inhibition of ATP-induced K+ efflux (cation free) in adherent HEK293 cells expressing human P2X7 receptor | Homo sapiens | 9 | ALA1134335 | cell-based format | Scientific Literature | |
| 8. | ALA751763 | F | Percent inhibition of ATP-induced K+ efflux (ethidium influx) in suspended HEK293 cells expressing human P2X7 receptor | Homo sapiens | 10 | ALA1134335 | cell-based format | Scientific Literature | |
| 9. | ALA751764 | F | Percent inhibition of ATP-induced K+ efflux (with cations) in adherent HEK293 cells expressing human P2X7 receptor | Homo sapiens | 8 | ALA1134335 | cell-based format | Scientific Literature | |
| 10. | ALA751765 | F | Evaluated for agonist activity against phospholipase C coupled recombinant human P2Y purinoceptor 2 (P2Y2) | 12 | ALA1135773 | assay format | Scientific Literature | ||
| 11. | ALA750158 | B | KB value was evaluated at the human P2Y purinoceptor 1 (P2Y1); IA menas inactive | 1 | ALA1135726 | single protein format | Scientific Literature | ||
| 12. | ALA750160 | B | KB value was evaluated at the human P2Y purinoceptor 1 (P2Y1) | 1 | ALA1135726 | single protein format | Scientific Literature | ||
| 13. | ALA750164 | B | pA2 value was evaluated against P2Y purinoceptor 1 | 2 | ALA1135726 | single protein format | Scientific Literature | ||
| 14. | ALA759187 | F | Evaluated for agonist activity against phospholipase C coupled P2Y purinoceptor 1 (P2Y1) of turkey erythrocytes | Meleagris gallopavo | 17 | ALA1135773 | assay format | Scientific Literature | |
| 15. | ALA759192 | F | In vitro antagonist activity at P2Y1 receptor in turkey erythrocyte membranes. | Meleagris gallopavo | 23 | ALA1132720 | cell membrane format | Scientific Literature | |
| 16. | ALA759342 | F | In vitro agonist activity at P2Y1 receptor in turkey erythrocyte membranes; No effect at 100 uM. | Meleagris gallopavo | 20 | ALA1132720 | cell membrane format | Scientific Literature | |
| 17. | ALA759343 | F | Antagonist activity for inhibition of PLC elicited by 10 nM 2-MeSADP at P2Y purinoceptor 1 in turkey erythrocyte membranes | Meleagris gallopavo | 24 | ALA1132720 | cell membrane format | Scientific Literature | |
| 18. | ALA759347 | F | Stimulation of phospholipase C (PLC) against [3H]inositol labeled Turkey Erythrocyte P2Y purinoceptor 1. | Meleagris gallopavo | 11 | ALA1133587 | assay format | Scientific Literature | |
| 19. | ALA759348 | B | P2Y purinoceptor 1 mediated PLC stimulation in turkey RBC, NE represents no effect | Meleagris gallopavo | 14 | ALA1133709 | single protein format | Scientific Literature | |
| 20. | ALA756289 | F | Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12) | 12 | ALA1135773 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!